Clinical trial

Phase 2 Study of DS-8500a in Patients With Type 2 Diabetes

NCT02222350

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2014-07-01

PhasePHASE2

Study timeline

Study start (unknown)2014-07-01Date precision: month

Registry last updated2019-02-12

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Type 2 Diabetes Mellitusunresolved

Interventions

10mg DS-8500a tabletDRUG

75mg DS-8500a tabletDRUG

placeboDRUG

Sponsors & collaborators

Daiichi Sankyo Co., Ltd.lead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02222350 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.